Efpeglenatide
2 papers
Latest
2 in 12 monthsAHA Scientific Sessions 2025 Abstract
Targeting Cerebrovascular Risk in Diabetes: GLP-1 Receptor Agonists as Neuroprotective Agents
Meta-analysis of randomised trialsGLP-1 receptor agonists
AHA Scientific Sessions 2025 Abstract
Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Dementia Risk in Type 2 Diabetes: A Comprehensive Bayesian Network Meta-Analysis
Meta-analysis of randomised trialsSGLT2 inhibitors